Error-correcting mechanisms are very important for cells, because with all the cellular activity constantly going on, malfunctions arise all the time. But when it comes to killing cancer cells, it is in the cells' best interest ...
Jan 27, 2023
0
95
Professor Wenbiao Hu from the QUT School of Public Health and Social Work said the team had looked at the possible influence of environmental changes given that liver cancer had increased in the face of decreases in known ...
Jan 19, 2023
0
5
With the only cure for liver cancer often being a transplantation, scientists are honing the selection of patients for this life-saving surgery and growing replacement livers in a lab.
Jan 10, 2023
0
2
A new review was published in Genes & Cancer on December 13, 2022, entitled, "Pathogenesis to management of hepatocellular carcinoma." In this review, researchers from multiple universities and medical centers across the ...
Jan 6, 2023
0
2
Lactate, a major product of glycolysis in mammals, is significantly increased in pathological states such as tumors, sepsis and autoimmune diseases, which is known as the Warburg effect. Despite being an important metabolic ...
Jan 4, 2023
0
34
A new research paper was published in Genes & Cancer entitled "Ectopic expression of lncRNA MVIH as a potential diagnostic biomarker in cervical cancer."
Dec 9, 2022
0
6
A new research paper titled "Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis" has been published in Oncotarget.
Dec 1, 2022
0
11
According to an accepted manuscript published in ARRS' American Journal of Roentgenology, diagnostic performance of LR-5 for hepatocellular carcinoma (HCC) diagnosis was not significantly different between modified contrast-enhanced ...
Nov 16, 2022
0
1
Researchers at VCU Massey Cancer Center have published new study findings that establish rationale for the use of a class of drugs known as MDA-9 inhibitors as a potential treatment option for aggressive liver cancer. The ...
Nov 3, 2022
0
16
Scientists at deCODE genetics, a subsidiary of Amgen, published today a large genome-wide association study on nonalcoholic fatty liver disease (NAFLD) in Nature Genetics. Sequence variants that associate with NAFLD were ...
Oct 24, 2022
0
19
